HPV and high-risk gene expression profiles predict response to chemoradiotherapy in head and neck cancer, independent of clinical factors

2010 ◽  
Vol 95 (3) ◽  
pp. 365-370 ◽  
Author(s):  
Monique C. de Jong ◽  
Jimmy Pramana ◽  
Joost L. Knegjens ◽  
Alfons J.M. Balm ◽  
Michiel W.M. van den Brekel ◽  
...  
2007 ◽  
Vol 213 (3) ◽  
pp. 283-293 ◽  
Author(s):  
NF Schlecht ◽  
RD Burk ◽  
L Adrien ◽  
A Dunne ◽  
N Kawachi ◽  
...  

Head & Neck ◽  
2007 ◽  
Vol 29 (12) ◽  
pp. 1083-1089 ◽  
Author(s):  
Jimmy Pramana ◽  
Nuno Pimentel ◽  
Ingrid Hofland ◽  
Lodewijk F. A. Wessels ◽  
Marie-Louise F. van Velthuysen ◽  
...  

2019 ◽  
Author(s):  
Shahan Mamoor

Differential gene expression analysis has the potential to illuminate fundamentals of biology by identifying key differences in transcription between cells, genotypes or diseases. I compared the expression profiles of 327 genes in a cohort of patients with head and neck cancer (1), grouped based on their survival at three years. Patients who were dead at three years possessed a unique “death signature” of forty genes whose expression was significantly different from that of survivors. This gene expression signature, associated with more rapid mortality in humans with head and neck cancer, may have clinical relevance in prognostic stratification and the genes themselves may have biological significance in the etiology of head and neck cancer.


HPB ◽  
2021 ◽  
Vol 23 ◽  
pp. S583
Author(s):  
M. Turgeon ◽  
B. Dwivedi ◽  
C. Herting ◽  
J. Keilson ◽  
S. Maithel ◽  
...  

Oral Oncology ◽  
2017 ◽  
Vol 74 ◽  
pp. 15-20 ◽  
Author(s):  
Gaurav S. Ajmani ◽  
Cheryl C. Nocon ◽  
Chi-Hsiung Wang ◽  
Mihir K. Bhayani

2006 ◽  
Vol 81 (2) ◽  
pp. 143-150 ◽  
Author(s):  
Guido B. van den Broek ◽  
Alfons J.M. Balm ◽  
Michiel W.M. van den Brekel ◽  
Michael Hauptmann ◽  
Jan H. Schornagel ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document